LumiraDx Limited (LMDXW) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Diagnostics & Research 산업에서 운영. 본사 소재지는 London, 영국. 현재 CEO는 Veronique Ameye EMBA,.
LMDXW 을(를) 보유 IPO 날짜 2021-09-29, 1,210 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $5.1M.
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
